LLTech

Cutting edge optical imaging systems for immediate prostate biopsies cancer diagnosis and real time breast cancer surgery guidance.

  • Stage $500K in TTM Revenue
  • Industry Biotechnology
  • Location Princeton, NJ, US
  • Currency USD
  • Founded July 2007
  • Employees 8
  • Website lltechimaging.com

Company Summary

LLTech develops cellular level optical biopsies imaging systems. They allow doctors to make a real time decision in the operating room instead of having to wait.

The target applications are:
- Cancer surgery improvement: reduce breast cancer re operations
- Immediate quality control to avoid recall patient (prostate, pancreas...)
- Corneal graft quality controll

LLTech will sell or lease imaging units associated with single use disposables.

Team

  • Founder of LLTech: experienced entrepreneur and manager
    Recognized know-how in technology and product development
    Established collaborations with major players in research and health institutions (UPMC, Curie Institute, Weill Cornell).
    Created high-speed internet sector of a major European internet provider (Tiscali), resulting in 7M€ revenue in the first year.
    Holds an MS in Life Sciences from Agro Paris Tech and an MBA from HEC Paris

  • Claude Boccara
    CSO

    Inventor of FFOCT technology - Scientific director at ESPCI Paris Tech
    Forty years experience in optics research
    Member of the National Research Committee and the steering committee of the Pierre Gilles de Gennes Foundation
    Recipient of the NIH Bed to Bedside Award; CNRS Bronze Award; City of Paris Award; Felix Robin Award (French Physics Society); James Smith IPPA Award
    Author of over 300 publications and inventor on 15 patents

Advisors

  • Business Advisor Mary has a background in consulting (Mc Kinsey company and independent), entrepreneur, company turnaround and board member of several early stage technology companies companies
    Thierry Thaure
    Advisor - Sales & Marketing Thierry was the 1st Head of sales of Intuitive Surgical and has grown the company to $40M revenues, then Acuray to $120 M, he as an extensive experience in medical devices and is now CEO of Cephea Valve
    Unconfirmed

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free